巨子生物二零二四年年报

目錄 2467183539576263656769126 2024 執行董事 頴 97927 獨立非執行董事 27 www.xajuzi.com 2367 頴FCG HKFCG (PE)  1855 1617 33191922 Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand CaymanKY1-1102Cayman Islands PO Box 309, Ugland HouseGrand CaymanKY1-1104Cayman Islands 1 6 69A101 2024 55.3957.2%21.5246.5%4562.9%836.3%12 2024 III 202442%74XVIIIV3PCTIII 100140SKU 1,7003,000130,0006,000cdf202470% XVIIZL 202410154497.6IVZL 202410545206.6CHO 202420253 5,538.857.2%2,151.546.5% 科研為基，持續投入多種專有成分的基礎研究、應用研究和產業化研究 2 106.542.1%1.9%18816774 IIIIII 2024618618TOP1TOP1TOP1 以誠意築產品，聚焦用戶需求，完善產品系列，打開市場空間 140SKU Human-like20242024618TOP1TOP1TOP1TOP1 +45.462.9% 202443R2024TOP2TOP1 2024TOP2TOP2TOP1TOP28.436.3% 315 加強推廣聲量，注重科學傳播，打造企業和品牌專業科學的形象 CSD2024(2024CDA)2024(CBA2024)2024AMWC China 202420242024 811 GMV202461860%100%202480%150% 全渠道差異化精細化運營，觸達服務各類人群，助力高效可持續增長 ++ CS/KA1,7003,0006506,000CS/KACDF18 4,134.21,404.674.6%25.4%5.9 31552522,00037 穩定生產供應，保障品控，讓消費者放心 SKU233 2025 積極承擔社會責任 1,400 收入 202412315,538.8202312313,524.157.2% (i) (i)(ii) (ii) (i)DTC(ii)(iii) 直銷 DTC DTC3,587.2202366.5%202464.8%(1)(2)(3) 377.12023112.5%20246.8% 169.9202392.0%20243.0% 向經銷商銷售 1,404.6202327.3%202425.4% (iii) 專業皮膚護理產品 4,541.8202362.9%202482.0%(1)(2)(3) 840.5202336.3%,202415.2%(1)(2) 202412314,546.9202312312,947.154.3% 2023123183.6%2024123182.1% 138.1202333.8%20242.5% 202412 312,008.2202312311,164.572.5% 保健食品及其他 18.4202315.0%20240.3% 20241231991.920231231577.071.9%(1)2023431.02024702.0(2)(3) 20241231106.52023123175.042.1%202420231.9%2.1% 20241231138.720231231103.034.8% 202412 3143.82023123130.9 20241231150.52023123196.755.7% 20241231 20241231396.020231231296.933.4% 202412 31202412315%202412315%AD232(4) 202412 312,061.7202312311,448.242.4% 202412312.10202312311.4940.9%202412312.06202312311.4839.2% 20241231 202412314,030.2202312312,504.061.0% 202412 31202412 31 20241231 20241231132.8202412 31251.2 20241231 2024 ESGESGESGESGESG 20241231 2024 20241231 ESGESG 財務風險 業務及行業有關的風險 123456 2024123126 2024 4,057 13 14.075% 2024123131AA 2024123130% 2024123130% 202412315% •28%•46%•5%•10% 202211 422,608,8002,261,20020,347,6000.0000124.30573.7 •11% 20245 16Juzi Holding Co.,Ltd(i)49.4033,220,000(ii)20245 21202452420245172024524 1,627(i)90%1,464.3(ii)10%162.7 3 20245 1652.9548.97 20241231 3.13 14.6 執行董事 獨立非執行董事 13.2013.2113.22 20246 13202412 31 2024202420242025 20241231 202412310.60210.59212025829 202561320256102025613202569161720256242025619202562420256181617 202412311,75820241231 20241231XV(a)XV78(b)352(c) (4)202412 3120211287,346,037 (5)202412 312021128449,800202312282023817600,000 (6)202412 312021128557,601202312282023817600,000 (7)202412312021128640,000202312282023817600,000 20241231336 (5)202412 3120211287,346,0377,346,037 20241231XV235% 107 受限制股份單位計劃 2021128 4.742021128202022926 (i)(ii) (i)(ii) 19,000,0001.83%19,000,000 20% 202412 3110,459,5021.01%3,113,465202412311% 5,508,429(i)3,631,43051.34.74(ii)1,876,99939.9520 202399,500,0009.61%19,900,0001.92% 2023年購股權計劃及2023年股份獎勵計劃 20238172023202320232023731 2023 12202320231% (i)(ii)(iii)2023 12 (a) (b)2023 (a)(b)5(c) (c) (d)202312 20232023 (e) 2023109 2023122812820,000,0000.000012023 2023122820,000,000(1)40%30%30%(2)10(3)(4)35.052023122733.7(5)(i)(ii)(iii)(6)6.25125 2023202379,500,0002023202319,900,0002023202379,627,0002023202319,900,00019,873,0001,015,059,0711.96% (i)(ii)1217.03D1%(iii)120.1% www.hkexnews.hkwww.xajuzi.com 20254 16Juzi Holding Co.,Ltd(i)66.6535,000,000(ii)2025417 20241231 5420211130221993720035601939939200372010220104201512201642020520027 582021113020005200230077520159201982020383579119887(i)(ii)(iii) 5220211130222000122003122020519957 3820231031620087201012201112018920194202212017122015320131020087 66202210642198412200922009220194200320247202112202361982119841219886 29202310320181020213(FRM)2021420209202072019112017620186(i)(ii) 54202210619961998199819992002201320042005200520072008201320202016201820162021199420092008201420182019Springer-Nature·2019202019917 199461996720045 462022106222001920061020078200872009220173201072010411322016615262017320236300017202211066620187202481772002460201742020800223620211202160611620011120127EMBA2004220167 56311990719947199432002720023202012199012 4418201222012720186201872025120192024720211220182201742016112024200572008620126 13.51B(1) 13.51B(1) C1C.2.1 獨立非執行董事 3.10(1)3.10(2)3.10A 董事會的組成 3.13 董事會與管理層 主席與首席執行官 C.2.1 董事會會議╱股東大會及董事出席情況 431111 26.4 董事服務協議 2021113020231032022106 培訓及專業發展 C.1.4 董事委任及重選連任 26.3 A B 董事獲得獨立觀點和意見的機制 審核委員會 3.213.10(2)3.21 (a) 董事會委員會 (b) (c) (d)(e)(f) 3202312 312024630 (a)(b)(c)(d)(e) 202412312.3 202412315761 (d) 提名委員會 3.27A (e) 1 (a) (b) (c) 3319192213.51(2) 薪酬委員會 3.25 17 (a)(b)(c)(d)(e)(f)(g)(h)(i) 1 E.1.5 8 公司管治委員會 (h)ESGESG 1(ESG) (a)(ESG)(b)(c)(d)(e)ESGESG 風險管理 內部控制 (i)(ii)(iii)20247 聯席公司秘書 頴頴頴 頴 C3